Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
José Carlos Millán-Calenti,1 Laura Lorenzo-López,1 Begoña Alonso-Búa,1 Carmen de Labra,2 Isabel González-Abraldes,1 Ana Maseda1 1Gerontology Research Group, Department of Medicine, Faculty of Health Sciences, Universidade da Coru&...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-02-01
|
| Series: | Clinical Interventions in Aging |
| Subjects: | |
| Online Access: | https://www.dovepress.com/optimal-nonpharmacological-management-of-agitation-in-alzheimerrsquos--peer-reviewed-article-CIA |
| _version_ | 1818345979703721984 |
|---|---|
| author | Millán-Calenti JC Lorenzo-López L Alonso-Búa B de Labra C González-Abraldes I Maseda A |
| author_facet | Millán-Calenti JC Lorenzo-López L Alonso-Búa B de Labra C González-Abraldes I Maseda A |
| author_sort | Millán-Calenti JC |
| collection | DOAJ |
| description | José Carlos Millán-Calenti,1 Laura Lorenzo-López,1 Begoña Alonso-Búa,1 Carmen de Labra,2 Isabel González-Abraldes,1 Ana Maseda1 1Gerontology Research Group, Department of Medicine, Faculty of Health Sciences, Universidade da Coruña, A Coruña, Spain; 2Research, Development and Innovation Department, Gerontological Complex La Milagrosa, Provincial Association of Pensioners and Retired People (UDP) from A Coruña, A Coruña, Spain Abstract: Many patients with Alzheimer’s disease will develop agitation at later stages of the disease, which constitutes one of the most challenging and distressing aspects of dementia. Recently, nonpharmacological therapies have become increasingly popular and have been proven to be effective in managing the behavioral symptoms (including agitation) that are common in the middle or later stages of dementia. These therapies seem to be a good alternative to pharmacological treatment to avoid unpleasant side effects. We present a systematic review of randomized controlled trials (RCTs) focused on the nonpharmacological management of agitation in Alzheimer’s disease (AD) patients aged 65 years and above. Of the 754 studies found, eight met the inclusion criteria. This review suggests that music therapy is optimal for the management of agitation in institutionalized patients with moderately severe and severe AD, particularly when the intervention includes individualized and interactive music. Bright light therapy has little and possibly no clinically significant effects with respect to observational ratings of agitation but decreases caregiver ratings of physical and verbal agitation. Therapeutic touch is effective for reducing physical nonaggressive behaviors but is not superior to simulated therapeutic touch or usual care for reducing physically aggressive and verbally agitated behaviors. Melissa oil aromatherapy and behavioral management techniques are not superior to placebo or pharmacological therapies for managing agitation in AD. Further research in clinical trials is required to confirm the effectiveness and long-term effects of nonpharmacological interventions for managing agitation in AD. These types of studies may lead to the development of future intervention protocols to improve the well-being and daily functioning of these patients, thereby avoiding residential care placement. Keywords: dementia, nonpharmacological, behavioral and psychological symptoms |
| first_indexed | 2024-12-13T17:10:59Z |
| format | Article |
| id | doaj.art-243769941aee4f948bc99f3f84c19cac |
| institution | Directory Open Access Journal |
| issn | 1178-1998 |
| language | English |
| last_indexed | 2024-12-13T17:10:59Z |
| publishDate | 2016-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical Interventions in Aging |
| spelling | doaj.art-243769941aee4f948bc99f3f84c19cac2022-12-21T23:37:32ZengDove Medical PressClinical Interventions in Aging1178-19982016-02-01Volume 1117518425664Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutionsMillán-Calenti JCLorenzo-López LAlonso-Búa Bde Labra CGonzález-Abraldes IMaseda AJosé Carlos Millán-Calenti,1 Laura Lorenzo-López,1 Begoña Alonso-Búa,1 Carmen de Labra,2 Isabel González-Abraldes,1 Ana Maseda1 1Gerontology Research Group, Department of Medicine, Faculty of Health Sciences, Universidade da Coruña, A Coruña, Spain; 2Research, Development and Innovation Department, Gerontological Complex La Milagrosa, Provincial Association of Pensioners and Retired People (UDP) from A Coruña, A Coruña, Spain Abstract: Many patients with Alzheimer’s disease will develop agitation at later stages of the disease, which constitutes one of the most challenging and distressing aspects of dementia. Recently, nonpharmacological therapies have become increasingly popular and have been proven to be effective in managing the behavioral symptoms (including agitation) that are common in the middle or later stages of dementia. These therapies seem to be a good alternative to pharmacological treatment to avoid unpleasant side effects. We present a systematic review of randomized controlled trials (RCTs) focused on the nonpharmacological management of agitation in Alzheimer’s disease (AD) patients aged 65 years and above. Of the 754 studies found, eight met the inclusion criteria. This review suggests that music therapy is optimal for the management of agitation in institutionalized patients with moderately severe and severe AD, particularly when the intervention includes individualized and interactive music. Bright light therapy has little and possibly no clinically significant effects with respect to observational ratings of agitation but decreases caregiver ratings of physical and verbal agitation. Therapeutic touch is effective for reducing physical nonaggressive behaviors but is not superior to simulated therapeutic touch or usual care for reducing physically aggressive and verbally agitated behaviors. Melissa oil aromatherapy and behavioral management techniques are not superior to placebo or pharmacological therapies for managing agitation in AD. Further research in clinical trials is required to confirm the effectiveness and long-term effects of nonpharmacological interventions for managing agitation in AD. These types of studies may lead to the development of future intervention protocols to improve the well-being and daily functioning of these patients, thereby avoiding residential care placement. Keywords: dementia, nonpharmacological, behavioral and psychological symptomshttps://www.dovepress.com/optimal-nonpharmacological-management-of-agitation-in-alzheimerrsquos--peer-reviewed-article-CIAdementianon-pharmacologicalbehavioral and psychological symptoms |
| spellingShingle | Millán-Calenti JC Lorenzo-López L Alonso-Búa B de Labra C González-Abraldes I Maseda A Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions Clinical Interventions in Aging dementia non-pharmacological behavioral and psychological symptoms |
| title | Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions |
| title_full | Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions |
| title_fullStr | Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions |
| title_full_unstemmed | Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions |
| title_short | Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions |
| title_sort | optimal nonpharmacological management of agitation in alzheimer rsquo s disease challenges and solutions |
| topic | dementia non-pharmacological behavioral and psychological symptoms |
| url | https://www.dovepress.com/optimal-nonpharmacological-management-of-agitation-in-alzheimerrsquos--peer-reviewed-article-CIA |
| work_keys_str_mv | AT millancalentijc optimalnonpharmacologicalmanagementofagitationinalzheimerrsquosdiseasechallengesandsolutions AT lorenzolopezl optimalnonpharmacologicalmanagementofagitationinalzheimerrsquosdiseasechallengesandsolutions AT alonsobuab optimalnonpharmacologicalmanagementofagitationinalzheimerrsquosdiseasechallengesandsolutions AT delabrac optimalnonpharmacologicalmanagementofagitationinalzheimerrsquosdiseasechallengesandsolutions AT gonzalezabraldesi optimalnonpharmacologicalmanagementofagitationinalzheimerrsquosdiseasechallengesandsolutions AT masedaa optimalnonpharmacologicalmanagementofagitationinalzheimerrsquosdiseasechallengesandsolutions |